Kevin C. Knightly
Net Worth
Last updated:
What is Kevin C. Knightly net worth?
The estimated net worth of Mr. Kevin C. Knightly is at least $25,937,875 as of 28 Feb 2024. He owns shares worth $1,005,251 as insider, has earned $15,092,624 from insider trading and has received compensation worth at least $9,840,000 in IQVIA Holdings Inc..
What is the salary of Kevin C. Knightly?
Mr. Kevin C. Knightly salary is $1,230,000 per year as Pres of Technology & Commercial Solutions in IQVIA Holdings Inc..
How old is Kevin C. Knightly?
Mr. Kevin C. Knightly is 64 years old, born in 1961.
What stocks does Kevin C. Knightly currently own?
As insider, Mr. Kevin C. Knightly owns shares in one company:
| Company | Title | Shares | Price per share | Total value |
|---|---|---|---|---|
| IQVIA Holdings Inc. (IQV) | Pres of Technology & Commercial Solutions | 5,251 | $191.44 | $1,005,251 |
What does IQVIA Holdings Inc. do?
IQVIA Holdings Inc. provides advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and related implementation services; real world solutions that enable life sciences and provider customers to generate and disseminate evidence, which informs health care decision making and improves patients' outcomes; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services. This segment also provides country level performance metrics related to sales of pharmaceutical products, prescribing trends, medical treatment, and promotional activity across various channels, including retail, hospital, and mail order; and measurement of sales or prescribing activity at the regional, zip code, and individual prescriber level. The Research & Development Solutions segment offers project management and clinical monitoring; clinical trial support; virtual trials; and strategic planning and design services, as well as central laboratory, genomic, bioanalytical, ADME, discovery, and vaccine and biomarker laboratory services. The Contract Sales & Medical Solutions segment provides health care provider and patient engagement services, and scientific strategy and medical affairs services. It serves pharmaceutical, biotechnology, device and diagnostic, and consumer health companies. The company has a strategic collaboration with HealthCore, Inc. The company was formerly known as Quintiles IMS Holdings, Inc. and changed its name to IQVIA Holdings Inc. in November 2017. IQVIA Holdings Inc. was founded in 1982 and is headquartered in Durham, North Carolina.
Kevin C. Knightly insider trading
IQVIA Holdings Inc.
Mr. Kevin C. Knightly has made 22 insider trades between 2017-2024, according to the Form 4 filled with the SEC.
The largest trade he's ever made was exercising 46,080 units of IQV stock on 3 May 2019. As of 28 Feb 2024 he still owns at least 5,251 units of IQV stock.
IQVIA Holdings key executives
IQVIA Holdings Inc. executives and other stock owners filed with the SEC:
- Mr. Ari Bousbib (64) Chairman, Pres & Chief Executive Officer
- Mr. Eric M. Sherbet (61) Executive Vice President, Gen. Counsel & Sec.
- Mr. Kevin C. Knightly (64) Pres of Technology & Commercial Solutions
- Mr. Ronald E. Bruehlman (64) Executive Vice President & Chief Financial Officer
- Mr. W. Richard Staub III (62) Pres of R&D Solutions